Association of serum soluble receptor for advanced glycation end-products with subclinical cerebrovascular disease: the Northern Manhattan Study (NOMAS).

Source:http://linkedlifedata.com/resource/pubmed/id/21316677

Download in:

View as

General Info

PMID
21316677